Can fMRI measuring striatal connectivity help predict response to antipsychotics?


Samei Huda steps into George Clooney’s shoes to discuss baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment.

[read the full story...]

Common mental health disorders linked with increased risk of violent reoffending in ex-prisoners


Ian Cummins considers the implications of a new cohort study of convicted prisoners in Sweden, which links psychiatric disorders with violent reoffending.

[read the full story...]

Childhood adversity and psychotic symptoms: how much can a growing evidence-base tell us?


Stephen Wood ponders the reliability of a recent systematic review and meta-analysis, which suggests that childhood adversity is significantly linked to an elevated risk of psychotic symptom persistence.

[read the full story...]

Psychodynamic therapy: time for a new approach?


Mark Smith summarises a recent narrative review about the effectiveness of psychodynamic therapy for depression, anxiety disorders, eating disorders, somatic disorders and other mental health conditions.

[read the full story...]

Does tobacco use cause psychosis?


Marcus Munafo appraises a recent systematic review and meta-analysis of prospective, case-control and cross-sectional studies, which finds that daily tobacco use is associated with an increased risk of psychosis and an earlier age at onset of psychotic illness.

[read the full story...]

Mood Matters: mood instability is common and associated with poor outcomes


Farhana Mann summarises an observational study of mood instability in people with mental illness, which explores its relationship with days spent in hospital, frequency of admissions, the likelihood of being sectioned and the chance of being prescribed antipsychotics and mood stabilisers.

[read the full story...]

Smoking cessation for people with severe mental illness


Sally Adams appraises and summarises the SCIMITAR pilot RCT, which investigates smoking cessation for people with severe mental ill health. The paper presents a highly promising bespoke intervention for smokers with bipolar disorder, psychosis or schizophrenia.

[read the full story...]

CBTp and medication in the treatment of psychosis: summarising the best evidence


Clive Adams presents a summary of the latest evidence for CBTp and medication in the treatment of psychosis. This blog was published alongside Clive’s talk at the Understanding Psychosis and Schizophrenia conference in Bath on 11 June 2015

[read the full story...]